These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11359135)

  • 1. Differentiation of recurrent nasopharyngeal carcinoma and skull base osteoradionecrosis by Epstein-Barr virus-derived latent membrane protein-1 gene.
    Hao SP; Tsang NM; Chang KP
    Laryngoscope; 2001 Apr; 111(4 Pt 1):650-2. PubMed ID: 11359135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma.
    Tsang NM; Chuang CC; Tseng CK; Hao SP; Kuo TT; Lin CY; Pai PC
    Cancer; 2003 Dec; 98(11):2385-92. PubMed ID: 14635073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs.
    Hao SP; Tsang NM; Chang KP
    Cancer; 2003 Apr; 97(8):1909-13. PubMed ID: 12673717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The time frame of Epstein-Barr virus latent membrane protein-1 gene to disappear in nasopharyngeal swabs after initiation of primary radiotherapy is an independently significant prognostic factor predicting local control for patients with nasopharyngeal carcinoma.
    Lin SY; Chang KP; Hsieh MS; Ueng SH; Hao SP; Tseng CK; Pai PC; Chang FT; Tsai MH; Tsang NM
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1339-46. PubMed ID: 16169672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular diagnosis of nasopharyngeal carcinoma using detection of Epstein-Barr virus latent membrane protein-1 gene in cervical metastatic lymph nodes.
    Khademi B; Mahmoudi J; Monabati A; Maghsoudi B; Ashraf MJ; Mohammadianpanah M; Tabibi N; Valibeigi B; Abedi E
    Am J Otolaryngol; 2009; 30(2):95-100. PubMed ID: 19239950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring tumor recurrence with nasopharyngeal swab and latent membrane protein-1 and epstein-barr nuclear antigen-1 gene detection in treated patients with nasopharyngeal carcinoma.
    Hao SP; Tsang NM; Chang KP
    Laryngoscope; 2004 Nov; 114(11):2027-30. PubMed ID: 15510036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
    Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
    Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Epstein-Barr virus-derived latent membrane protein-1 gene in various head and neck cancers: is it specific for nasopharyngeal carcinoma?
    Tsang NM; Chang KP; Lin SY; Hao SP; Tseng CK; Kuo TT; Tsai MH; Chung TC
    Laryngoscope; 2003 Jun; 113(6):1050-4. PubMed ID: 12782821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of syndecan-1 (CD138) in nasopharyngeal carcinoma is correlated with advanced stage and poor prognosis.
    Chen CL; Ou DL
    Hum Pathol; 2006 Oct; 37(10):1279-85. PubMed ID: 16949936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of rAAV-mediated RNA interference against EB virus-encoded latent membrane protein 1 on nasopharyngeal carcinoma cell proliferation and metastasis in nude mice].
    Liu X; Liu X; Li G; Zhang B; Wang L; Li XH; Li XP
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):611-4. PubMed ID: 19403376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P; De Matteo E; Merediz A; Preciado MV
    Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasopharyngeal carcinoma in Indonesia has a low prevalence of the 30-base pair deletion of Epstein-Barr virus latent membrane protein 1.
    Nurhantari Y; Emoto N; Rahayu P; Matsuo M
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):98-105. PubMed ID: 12971521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment on osteoradionecrosis of skull base after radiotherapy for nasopharyngeal carcinoma].
    Huang XM; Zheng YQ; Mai HQ; Zhou H; Liu X; Deng MQ; Mi HQ; Xu G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Sep; 39(9):558-61. PubMed ID: 15606008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus latent membrane protein does not inhibit differentiation and induces tumorigenicity of human epithelial cells.
    Nicholson LJ; Hopwood P; Johannessen I; Salisbury JR; Codd J; Thorley-Lawson D; Crawford DH
    Oncogene; 1997 Jul; 15(3):275-83. PubMed ID: 9233762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of interleukin-8 by Epstein-Barr virus latent membrane protein-1 and its correlation to angiogenesis in nasopharyngeal carcinoma.
    Yoshizaki T; Horikawa T; Qing-Chun R; Wakisaka N; Takeshita H; Sheen TS; Lee SY; Sato H; Furukawa M
    Clin Cancer Res; 2001 Jul; 7(7):1946-51. PubMed ID: 11448908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma.
    Huang XM; Zheng YQ; Zhang XM; Mai HQ; Zeng L; Liu X; Liu W; Zou H; Xu G
    Laryngoscope; 2006 Sep; 116(9):1626-31. PubMed ID: 16954993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
    Ho CH; Chen CL; Li WY; Chen CJ
    Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma.
    Chang KP; Hao SP; Lin SY; Ueng SH; Pai PC; Tseng CK; Hsueh C; Hsieh MS; Yu JS; Tsang NM
    Laryngoscope; 2006 Apr; 116(4):541-6. PubMed ID: 16585856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.